Bristol-Myers Squibb to Take Part in Evercore ISI Biopharma Conference
November 22 2017 - 6:59AM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will take part in the
Evercore ISI Biopharma Conference on Wednesday, November 29, 2017,
in Boston. Fouad Namouni, senior vice president, head of Oncology
Development, will answer questions about the company at 11:45 a.m.
ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171122005003/en/
Bristol-Myers Squibb CompanyMedia:Ken Dominski,
609-252-5251ken.dominski@bms.comorInvestors:Tim Power,
609-252-7509timothy.power@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024